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Background Previous studies on childhood cancer and nuclear power plants
(NPPs) produced conflicting results. We used a cohort approach
to examine whether residence near NPPs was associated with leu-
kaemia or any childhood cancer in Switzerland.
Methods We computed person-years at risk for children aged 0–15 years born
in Switzerland from 1985 to 2009, based on the Swiss censuses
1990 and 2000 and identified cancer cases from the Swiss
Childhood Cancer Registry. We geo-coded place of residence at
birth and calculated incidence rate ratios (IRRs) with 95% confi-
dence intervals (CIs) comparing the risk of cancer in children born
<5 km, 5–10 km and 10–15 km from the nearest NPP with children
born415 km away, using Poisson regression models.
Results We included 2925 children diagnosed with cancer during 21 117 524
person-years of follow-up; 953 (32.6%) had leukaemia. Eight and
12 children diagnosed with leukaemia at ages 0–4 and 0–15 years,
and 18 and 31 children diagnosed with any cancer were born
<5 km from a NPP. Compared with children born 415 km away,
the IRRs (95% CI) for leukaemia in 0–4 and 0–15 year olds were
1.20 (0.60–2.41) and 1.05 (0.60–1.86), respectively. For any cancer,
corresponding IRRs were 0.97 (0.61–1.54) and 0.89 (0.63–1.27).
There was no evidence of a dose–response relationship with dis-
tance (P40.30). Results were similar for residence at diagnosis
and at birth, and when adjusted for potential confounders.
Results from sensitivity analyses were consistent with main results.
Conclusions This nationwide cohort study found little evidence of an association
between residence near NPPs and the risk of leukaemia or any
childhood cancer.
Keywords Childhood, cancer, leukaemia, ionizing radiation, nuclear power
plants, population based, cancer registry
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Introduction
Since Black reported a cluster of children with leu-
kaemia near Sellafield in 1984,1 numerous studies
investigated cancer incidence near nuclear power
plants (NPP), with conflicting results. Some found
an increased risk also at places where NPPs were
planned but not built, concluding that factors other
than radiation might be responsible.2,3 A recent case–
control study from Germany, which reported odds
ratios (ORs) of 1.61 for all cancers and 2.19 for leu-
kaemia in 0–4 year olds living <5 km from a NPP,
refuelled the debate on a possible link between
NPPs and childhood cancer.4,5
Most previous analyses were ecological and may
have been affected by exposure misclassification and
confounding.6–11 The German case–control study was
criticized for potential selection and participation
bias.4,5,12,13 A recent Finnish study combining eco-
logical, cohort and case–control analyses was small,
with no children living <5 km from NPPs.14 All pre-
vious studies analysed residence at diagnosis. Given
the higher vulnerability to radiation of fetuses and
infants and the latency between radiation exposure
and cancer development, residence at birth might be
more relevant.15
We investigated the risk of childhood leukaemia and
all childhood cancers in the vicinity of Swiss NPPs,
using a cohort approach with person-years derived
from the Swiss censuses 1990 and 2000 and incident
cases from the Swiss Childhood Cancer Registry
(SCCR). We analysed distance of residence at birth
to the nearest NPP in the main analysis, and distance
to residence at diagnosis in a secondary analysis.
Outcomes of interest were leukaemia and all cancers
diagnosed at ages 0–4 (<5) and 0–15 (<16) years. We
adjusted for confounders, included other nuclear in-
stallations (research reactors and storage sites), and
locations where NPPs were planned but not built, and
assessed the robustness of the results in sensitivity
analyses.
Methods
Nuclear facilities in Switzerland
Figure 1 shows the location of Switzerland’s five
NPPs: Beznau I and II (in operation since 1969 and
1971), Leibstadt (6 km from Beznau, since 1984),
Mu¨hleberg (since 1972) and Go¨sgen (since 1979).
Other nuclear facilities include three research reactors
(Universities of Lausanne and Basel and Paul Scherrer
Institute [PSI] in Villigen, operating since 1983, 1959
and 1957, respectively), a prototype reactor (Lucens,
1968–69, shut down after a partial meltdown) and an
interim storage facility in Wu¨renlingen (since 2001).
Airborne and liquid radioactive discharges and direct
radiation in the vicinity of facilities are monitored.16
Emissions are comparable to those reported from
France, Germany and the UK.13 In 2009, the total
exposure to ionizing radiation of the Swiss population
was estimated at 5.5 mSv/year, including 3.2 mSV
from radon, 1.2 mSv from medical and 0.75 mSV
from cosmic and terrestrial radiation.16 Among
people living in the vicinity of a NPP, a small fraction
of the annual exposure (<0.01 mSv/year) was attrib-
utable to discharges from the NPP. At five sites
(Graben, Inwil, Kaiseraugst, Ru¨thi, Verbois), NPPs
had been planned but not built.
Definition of birth and resident cohorts
We analysed two cohorts: a birth cohort and a resi-
dent cohort. For both cohorts, person-time at risk was
calculated based on the censuses 1990 and 2000 using
data from the Swiss National Cohort.17 The birth
cohort included all children born in Switzerland be-
tween January 1985 and December 2009 and
person-time at risk was measured from birth. The
resident cohort included all 0–15 year olds residing
in Switzerland for any amount of time between
January 1985 and December 2009. Person-time at
risk was measured from the date the child entered
the cohort.
All children diagnosed with cancer 1985–2009 and
registered in the population-based Swiss Childhood
Cancer Registry (SCCR, www.childhoodcancerregistry.
ch)18,19 were eligible. The SCCR includes all children
diagnosed with leukaemia, malignant solid tumours
or brain tumours classified according to the
International Classification of Childhood Cancer
(ICCC3).20 Children with Langerhans cell histiocytosis
are also included. Completeness of registration is
490% and incidence rates are similar to other coun-
tries with national registries.18,19,21
Exposure assessment and geo-coding
Study exposures were the distance of the residence
from the nearest nuclear facility at birth (birth
cohort, main analysis) or the distance at diagnosis
(resident cohort, secondary analysis). We considered
(i) distance to the nearest NPP, (ii) smallest distance
to any nuclear facility and (iii) distance to nearest
planned but not built NPP. Address at diagnosis is
collected routinely in the SCCR. For this study, we
additionally obtained resident histories back to birth
by contacting the communal population registries.
Addresses of cancer cases were geo-coded by the
Swiss Federal Statistical Office (FSO) using specia-
lized software, or coded manually using the fixpoint
data service (FPDS) of the Swiss Federal Office of
Topography (http://map.fpds.admin.ch). The census
data include geo-codes of almost all residents.
Distances were computed using ArcGIS (ArcGIS 9.3;
Redlands, CA, USA).
Potential confounders
Informed by the literature,22 we considered the fol-
lowing potential confounders: (i) background ionizing
radiation (cosmic, terrestrial, artificial and total radi-
ation); (ii) electromagnetic radiation from radio and
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Figure 1 Maps showing sites of nuclear facilities and population density in Switzerland. Locations of NPPs, research
facilities, the interim storage facility and sites where NPPs were planned but never built (upper map) and population
density in 2000 in quintiles (lower map)
NPP, nuclear power plant; EPFL, E´cole Polytechnique Fe´de´rale de Lausanne; Uni, University; PSI, Paul Scherrer Institute
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TV transmitters (from an area exposure model),
multi-track railways and high voltage (5200 kV)
power lines (indexed by distance to nearest installa-
tion); (iii) carcinogens related to traffic exhaust (dis-
tance to major roads); (iv) agricultural pesticides
(distance to the nearest land use plot with fruit
trees, vineyards and golf courses); (v) socio-economic
status measured at community level based on income,
education and job position (Sotomo Index);23 (vi)
population mixing and exposure to childhood infec-
tions (indexed by average number of children per
household in the community and degree of urbaniza-
tion). We also adjusted for distance to the nearest
paediatric cancer centre, which may have affected
the probability of registration in the SCCR.
Details on data sources and variable definitions
are given in Supplementary Appendix 1, available as
Supplementary Data at IJE online.
Statistical analysis
We used Poisson regression to estimate incidence rate
ratios (IRRs) and 95% CIs, comparing children living
<5 km, 5–10 km and 10–15 km from the nearest NPP
with those living415 km away, adjusting for sex, age
and calendar year. We calculated the number of cases
and person-years at risk attributable to each combin-
ation of exposure (four strata), sex, age (five or 16
strata), calendar year (1985–2009, 25 strata) and one
potential confounder. Due to small numbers, we only
included one confounder at a time. For each cohort,
we calculated person-years in 1990 and 2000 using
census data and, from these values, person-years
before (1985–89), between (1991–99) and after
the censuses (2001–09) by linear extra- and
interpolation.24 The calculations are described in
detail in Supplementary Appendix 1, available as
Supplementary Data at IJE online.
We performed 10 additional analyses, including
eight sensitivity analyses (the rationale for these ana-
lyses is given in Box 1): (1) accounting for main dis-
persal directions of airborne emissions from NPPs (see
Figure E31 in Supplementary Appendix 2, available as
Supplementary Data at IJE online); (2) excluding chil-
dren living450 km from a NPP; (3) excluding calen-
dar years 1985–90 and 2009, when registration in the
SCCR was less complete; (4) excluding children born
abroad or before 1985 from the resident cohort; (5)
using an alternative method for calculating person-
years (see Supplementary Appendix 1, available as
Supplementary Data at IJE online); (6) recalculating
distance to nearest NPP by excluding each NPP in
turn; (7) stratifying by calendar period (1985–94;
1995–2009); (8) including only children who remained
in the community where they were born.
Finally, we performed two analyses using distance
to nearest NPPs as a continuous rather than a cat-
egorical variable (Box 1): (9) we used 1/(distance in
km) as the exposure measure; (10) we compared dis-
tances to nearest NPPs between cases and the
population at risk using two-sample t-tests and
the Mann–Whitney U-test (see Supplementary
Appendix 2, available as Supplementary Data at IJE
online). The latter approach is related to the
case-specular method in case–control research.25
Stata version 11.0 (StataCorp, College Station, TX,
USA) was used for all analyses.
Results
Selection of childhood cancer cases and
geo-coding
Geo-coded addresses were available for 2925 children
diagnosed in the birth cohort and for 4090 cases in
the resident cohort (Figure 2). Precision was <50 m
for 95% of geo-codes. Among cases in the birth
cohort, 1976 (67.6%) had not moved between birth
and diagnosis, 648 (22.2%) had moved once, 191
(6.5%) twice and 110 (3.8%) three times or more.
Of the 1 240 198 and 1 333 538 children aged 0–15
years registered in the censuses 1990 and 2000,
1 191 536 (96.1%) and 1 301 465 (97.6%), respectively,
had geo-coded addresses.
Characteristics of childhood cancer cases
Among the 2925 cancer cases in the birth cohort, 953
(32.6%) had been diagnosed with leukaemia, 303
(10.4%) with lymphoma and 594 (20.3%) with a neo-
plasm of the central nervous system (Table 1). The
distribution of diagnoses was similar in the 4090 chil-
dren included in the resident cohort, and comparable
to the SCCR in general.18,19 The 1250 and 85 children
excluded from birth and resident cohorts, respectively,
had higher proportions of lymphomas and bone tu-
mours as they were, on average, older at diagnosis
(Table 1).
Incidence of childhood cancer in birth and
resident cohorts
Observation time in the birth cohort totalled
21 117 524 person-years. The incidence per 100 000
person-years in children aged 0–15 years was 4.51
(95% CI 4.24–4.81) for leukaemia and 13.85
(13.36–14.36) for all cancers. The corresponding fig-
ures for the resident cohort were 31 279 898 person-
years at risk, 4.30 (95% CI 4.08–4.54) and 13.08 (95%
CI 12.68–13.48) per 100 000 person-years. Table E1 in
Supplementary Appendix 2 presents incidence rates
for leukaemia and all cancers by sex, age and calen-
dar year. Incidence was higher in boys than in girls,
higher in younger children and slightly higher in
recent years.
Incidence by distance to nuclear facilities
In the birth cohort, 8 and 12 children diagnosed
with leukaemia at ages 0–4 and 0–15 years, respect-
ively, and 18 and 31 children diagnosed with any
cancer lived <5 km from a NPP at birth (Table 2,
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and Figure 3). IRRs (95% CI) for leukaemia diagnosed
in 0–4 and 0–15 year olds, comparing children in this
inner circle with children living 415 km away, were
1.20 (0.60–2.41) and 1.05 (0.60–1.86), respectively.
The corresponding IRRs for any cancer were 0.97
(0.61–1.54) and 0.89 (0.63–1.27). In the 5–10 km
zone, IRRs tended to be <1 for all outcomes; in the
10–15 km zone they were close to 1 for 0–15 year olds
and slightly41 in 0–4 year olds. A similar variation of
IRRs around 1 was observed for distance to any
nuclear facility and for distance to sites of NPPs
that were planned but never built (Table 2 and
Figure 3). In all analyses, the 95% CIs included 1
and there was little evidence of a dose–response rela-
tionship (P-value from test for linear trend 50.3).
In the resident cohort, 11 and 20 children in age
groups 0–4 and 0–15 years, respectively, lived within
5 km of a NPP when diagnosed with leukaemia, and
23 and 50 children, respectively, were diagnosed with
any cancer (Table 3 and Figure 4). Compared with
children living 415 km away, IRRs for children in
the 0–5 km zone were 41 for leukaemia in 0–4 and
0–15 year olds: 1.41 (95% CI 0.78–2.55) and 1.24
(95% CI 0.80–1.94). Corresponding IRR for any
cancer were 1.11 (95% CI 0.74–1.67) and 1.03
(0.78–1.36). For the 5–10 km zone, IRRs were
<1 for both outcomes and age groups. In the analyses
including any nuclear facility, IRRs were again41 in
the 5 km zone for leukaemia in 0–4 and 0–15 year
olds (Table 3 and Figure 4). IRRs by distance to
planned but not built NPPs were close to 1 (Table 3,
and Figure 4). Again, in all analyses the 95% CIs
included 1 and P-values for a linear trend across dis-
tance categories were 50.1.
Figure 2 Flow chart of selection of children with childhood cancer
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Adjustment for confounders and sensitivity
analyses
Results were closely similar when adjusting, one at
a time, for potential confounders (Figures E1–E30
of Supplementary Appendix 2, available as Supple-
mentary Data at IJE online). As shown in Figure 5,
the results from the sensitivity analyses were closely
similar to the main analysis (detailed results are
shown in Figures E31–E48 of Supplementary
Appendix 2, available as Supplementary Data at IJE
online). In the analyses using 1/(distance in km), esti-
mated IRRs were close to 1 for the birth cohort and
41 for the resident cohort, with 95% CIs including 1
(Figure E49 in Supplementary Appendix 2, available
as Supplementary Data at IJE online). The results of
the direct comparison of distances to nearest NPP
Table 2 Incidence of childhood cancer in birth cohort according to distance to nuclear power plant, any nuclear facility and
NPPs that were planned but never built
Age 0–4 years Age 0–15 years
Cases
PY at risk in
100 years
IR per
100 000 PY
IRR
(95% CI)a Cases
PY at risk in
100 years
IR per
100 000 PY
IRR
(95% CI)a
Distance to nearest NPP (km)
Leukaemias
0–5 8 1000 8.00 1.20 (0.60–2.41) 12 2548 4.71 1.05 (0.60–1.86)
5–10 12 3011 3.99 0.60 (0.34–1.06) 25 7631 3.28 0.73 (0.49–1.09)
10–15 31 4194 7.39 1.10 (0.77–1.58) 47 10487 4.48 0.99 (0.74–1.33)
415 522 77 375 6.75 1 869 190 509 4.56 1
All cancers
0–5 18 1000 17.99 0.97 (0.61–1.54) 31 2548 12.17 0.89 (0.63–1.27)
5–10 43 3011 14.28 0.77 (0.57–1.04) 89 7631 11.66 0.85 (0.69–1.05)
10–15 92 4194 21.94 1.17 (0.95–1.44) 156 10 487 14.88 1.08 (0.92–1.27)
415 1465 77 375 18.93 1 2649 190 509 13.91 1
Distance to nearest nuclear facility (NPP, research, or storage) (km)
Leukaemias
0–5 39 5034 7.75 1.15 (0.83–1.59) 65 12 184 5.34 1.16 (0.90–1.50)
5–10 32 6013 5.32 0.79 (0.55–1.13) 57 14 624 3.90 0.85 (0.65–1.12)
10–15 41 5858 7.00 1.05 (0.76–1.44) 62 14 547 4.26 0.95 (0.73–1.22)
415 461 68 674 6.71 1 769 169 821 4.53 1
All cancers
0–5 94 5034 18.67 0.98 (0.80–1.21) 180 12 184 14.77 1.07 (0.92–1.24)
5–10 103 6013 17.13 0.90 (0.74–1.11) 200 14 624 13.68 0.99 (0.86–1.14)
10–15 130 5858 22.19 1.18 (0.99–1.42) 217 14 547 14.92 1.09 (0.95–1.25)
415 1291 68 674 18.80 1 2328 169 821 13.71 1
Distance to nearest planned NPP (km)
Leukaemias
0–5 5 1387 3.60 0.54 (0.22–1.31) 13 3443 3.78 0.85 (0.49–1.47)
5–10 53 6627 8.00 1.20 (0.90–1.60) 79 16 102 4.91 1.09 (0.87–1.38)
10–15 55 8126 6.77 1.01 (0.77–1.34) 97 19 557 4.96 1.10 (0.89–1.36)
415 460 69 439 6.62 1 764 172 073 4.44 1
All cancers
0–5 26 1387 18.74 0.98 (0.67–1.45) 48 3443 13.94 1.00 (0.75–1.33)
5–10 127 6627 19.16 1.00 (0.83–1.20) 223 16 102 13.85 0.98 (0.86–1.13)
10–15 145 8126 17.84 0.93 (0.78–1.10) 260 19 557 13.30 0.94 (0.83–1.07)
415 1320 69 439 19.01 1 2394 172 073 13.91 1
aAdjusted for sex, age and calendar year at diagnosis.
PY, person-year; IR, incidence rate; IRR, incidence rate ratio; NPP, nuclear power plant.
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between childhood cancer cases and the population at
risk are shown in Table E2 in Supplementary
Appendix 2, available as Supplementary Data at IJE
online. Among infants living <50 km from a NPP,
cases born in 1988–92 and diagnosed with leukaemia
at 0–4 years lived on average 28.70 km (SD 11.53 km)
from a NPP at birth compared with 27.62 km
(11.85 km) for the population at risk in 1990 (P-
value Mann–Whitney test: 0.38). Results were similar
for other outcomes. Differences were found in 2000
for any cancer in 0–4 years, with cases living slightly
closer to NPPs (P¼ 0.01). However, histograms show
that cases were mainly overrepresented at intermedi-
ate rather than small distances from NPPs (Figures
E50–51 in Supplementary Appendix 2, available as
Supplementary Data at IJE online).
Discussion
This nationwide census-based cohort study found
little evidence of an association between residence
near NPPs and the risk of leukaemia or any childhood
cancer, either for residence at birth or at diagnosis. In
particular, there was no evidence for a dose–response
over distance categories, results were not changed by
adjustment for confounders and remained robust in
numerous sensitivity analyses designed to evaluate
potential biases related to the study population, mod-
elling of person-years or definition of exposure.
However, due to the small number of cases, statistical
power was limited and we cannot exclude a moder-
ately increased or reduced incidence in the 0–5 km
zone, particularly for leukaemia in children aged 0–4
years.
Methodological considerations
A major strength of this study is the nationwide
cohort approach, leaving little room for selection
bias. Only two other studies used a cohort ap-
proach14,24 and one of them did not study the 5 km
zone around NPPs.14 The German case–control study
was criticized for control selection bias, with controls
selected retrospectively from community records and
community response rates varying by distance to
NPPs.4,5 By using census data to compute person-
years and a national cancer registry to obtain incident
cases, we avoided participation bias. There was no
evidence that variation in the completeness of the
SCCR biased our results: findings were similar when
we adjusted for distance to the nearest paediatric
cancer centre, excluded children living further than
50 km from any NPP or excluded calendar years
with poorer registration coverage. As all Swiss NPPs
were built in populated regions near large paediatric
cancer centres (Bern, Aarau, Zurich) any bias would
likely have strengthened rather than attenuated
associations.
Our main analysis was based on residence at birth:
humans are particularly sensitive to ionizing radiation
during intrauterine development and infancy;15 there
Figure 3 Results for birth cohort. Incidence rate ratios adjusted for sex, age and year at diagnosis and 95% CIs comparing
children living in the inner 5 km, 5–10 km and 10–15 km zones with children outside the 15 km zone. Results for nuclear
power plants (NPPs); any nuclear facility including NPPs, research and storage facilities; and sites of planned but not built
NPPs are shown
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is a latency between exposure and development of
cancer;15 and young families tend to move.
Therefore, studies based on residence at diagnosis
might suffer from exposure misclassification, and ad-
dress at birth will be a better proxy for the place of
residence during pregnancy. Whereas most previous
studies were ecological using community mid-points
to determine the distance to the nearest NPP, our
study used precise (<50 m in most cases) residential
locations, thus allowing the calculation of exact dis-
tances. Finally, we adjusted for many potential con-
founders, including background ionizing radiation,26
non-ionizing radiation,27 traffic-related carcinogens28
and proxies for population mixing.29
The main weakness of our study is the relatively
small sample size, particularly of 0–4 year olds living
Table 3 Incidence of childhood cancer in resident cohort according to distance to nuclear power plant, any nuclear facility
and NPPs that were planned but never built
Age 0–4 years Age 0–15 years
Cases
PY at risk in
100 years
IR per
100 000 PY
IRR
(95% CI)a Cases
PY at risk in
100 years
IR per
100 000 PY
IRR
(95% CI)a
Distance to nearest NPP (km)
Leukaemias
0–5 11 1094 10.06 1.41 (0.78–2.55) 20 3784 5.29 1.24 (0.80–1.94)
5–10 20 3297 6.07 0.85 (0.54–1.32) 35 11 255 3.11 0.73 (0.52–1.02)
10–15 34 4542 7.49 1.05 (0.74–1.48) 66 15 039 4.39 1.02 (0.80–1.31)
415 615 85 579 7.19 1 1224 282 721 4.33 1
All cancers
0–5 23 1094 21.03 1.11 (0.74–1.67) 50 3784 13.21 1.03 (0.78–1.36)
5–10 57 3297 17.29 0.91 (0.70–1.18) 133 11 255 11.82 0.92 (0.77–1.10)
10–15 105 4542 23.12 1.21 (0.99–1.47) 222 15 039 14.76 1.14 (0.99–1.30)
415 1645 85 579 19.22 1 3685 282 721 13.03 1
Distance to nearest nuclear facility (NPP, research, or storage) (km)
Leukaemias
0–5 47 5389 8.72 1.21 (0.90–1.62) 90 17 244 5.22 1.19 (0.96–1.48)
5–10 42 6687 6.28 0.86 (0.63–1.18) 74 22 367 3.31 0.76 (0.60–0.97)
10–15 39 6480 6.02 0.83 (0.60–1.15) 91 21 545 4.22 0.98 (0.79–1.21)
415 552 75 955 7.27 1 1090 251 643 4.33 1
All cancers
0–5 104 5389 19.30 0.99 (0.81–1.21) 254 17 244 14.73 1.13 (0.99–1.28)
5–10 125 6687 18.69 0.96 (0.80–1.16) 286 22 367 12.79 0.99 (0.87–1.11)
10–15 139 6480 21.45 1.12 (0.94–1.33) 312 21 545 14.48 1.13 (1.00–1.26)
415 1462 75 955 19.25 1 3238 251 643 12.87 1
Distance to nearest planned NPP (km)
Leukaemias
0–5 12 1563 7.68 1.07 (0.60–1.89) 24 5222 4.60 1.09 (0.72–1.63)
5–10 58 7270 7.98 1.11 (0.85–1.46) 112 23 555 4.76 1.11 (0.92–1.35)
10–15 60 8950 6.70 0.93 (0.71–1.22) 130 29 322 4.43 1.04 (0.87–1.24)
415 550 76 728 7.17 1 1079 254 700 4.24 1
All cancers
0–5 35 1563 22.39 1.15 (0.82–1.61) 70 5222 13.40 1.03 (0.81–1.31)
5–10 141 7270 19.39 0.99 (0.83–1.18) 323 23 555 13.71 1.04 (0.93–1.16)
10–15 159 8950 17.77 0.90 (0.77–1.06) 370 29 322 12.62 0.95 (0.86–1.06)
415 1495 76 728 19.48 1 3327 254 700 13.06 1
aAdjusted for sex, age and calendar year at diagnosis.
PY, person-year; IR, incidence rate; IRR, incidence rate ratio; NPP, nuclear power plant.
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Figure 5 Comparison of results of main and sensitivity analyses. Incidence rate ratios adjusted for sex, age and year at
diagnosis and 95% CIs comparing children living <5 km with children living415 km from a nuclear power plant. Results
are shown for the birth cohort and are adjusted for sex, age and year at diagnosis. Analyses numbered as in Box 1
Figure 4 Results for resident cohort. Incidence rate ratios adjusted for sex, age and year at diagnosis and 95% CIs
comparing children living in the inner 5 km, 5–10 km and 10–15 km zones with children outside the 15 km zone. Results
for nuclear power plants (NPPs); any nuclear facility including NPPs, research and storage facilities; and sites of planned
but not built NPPs are shown
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close to NPPs, resulting in large CIs around estimated
IRRs. Second, we could not adjust for some potential
individual or family level confounders, such as health
behaviours, diet, infections, medical radiation or
medications. However, with the exception of high
dose radiation treatment, these exposures are all
weak risk factors (if at all) and thus unlikely to be
strong confounders.22 Another methodological limita-
tion of our and other studies14,24 was the need to
compute person-years from census data. We ac-
counted for non-linear population fluctuations at
the aggregate level, but internal migration was only
accounted for by linear inter-/extrapolation of
person-years between and around census years.
Finally, the birth cohort did not include cases who
had emigrated before diagnosis. However, data from
the Swiss National Cohort show that only 2% (4%) of
<1 year olds in the 1990 census had emigrated in the
first 4 (15) years of life, making emigration an un-
likely source of bias.
Our results in context with the literature
Most previous analyses, summarized in recent re-
views,13,30,31 were ecological, using routine data to
calculate standardized mortality or incidence ratios.
Studies of local clusters near single NPPs have been
performed for 198 different sites in 10 countries.
Among these, only three clear clusters emerged
(Seascale near Sellafield, Dounreay, Kruemmel), two
relating to nuclear processing rather than power gen-
erating stations. A meta-analysis of 136 single nuclear
facilities concluded that there was evidence of an
excess leukaemia risk near NPPs.30 However, the
methodology of this study has been criticized.32 A
total of 25 studies from eight countries analysed leu-
kaemia risk in the vicinity of several NPPs.31 Overall,
these show no consistent evidence for an increased
risk of childhood leukaemia near NPPs. Few, how-
ever, have specifically investigated leukaemia in
under-fives living close (<5 km) to NPPs.4,9,13,24,33,34
Among these, the German case–control study, the
only other study using exact distances, found elevated
ORs for leukaemia (OR 2.19, lower one-sided confi-
dence limit 1.51) and all cancers (OR 1.61, lower one-
sided confidence limit 1.26).4,5 The Committee on
Medical Aspects of Radiation in the Environment
(COMARE) recently analysed the data for children
aged 0–4 years when diagnosed with leukaemia or
non-Hodgkin lymphoma 1969–2004.13 The analysis
was based on electoral wards and postcode zones
near 13 NPPs in the UK and showed no evidence
for an increased risk in the 5-km perimeter: the rela-
tive risk was 1.01 (compared with the national aver-
age), with relatively narrow 95% CI (0.70–1.47).
Interestingly, the analysis of six possible locations
for NPPs, where no installation was constructed,
showed an increased risk: 1.72 (95% CI 1.12–2.52),
for reasons that are not understood.13 A similar
approach in France found no evidence for increased
IRRs in the 5 km zone (IRR 0.96, 95% CI 0.31–2.24).31
Population-attributable risks and potential
causes
Assuming the association is causal and the point es-
timate from the analysis of the birth cohort
(IRR 1.20) reflects the true underlying effect for leu-
kaemia, 1.3 (0.2%) of the 573 leukaemia cases
observed during the 25-year study period in
0–4 year olds would be attributable to living <5 km
from a NPP. If we assume that the upper confidence
limit (IRR 2.41) reflects the true underlying effect, 4.7
cases (0.8%) would be attributable to living <5 km
from a NPP. Repeating the analysis for all cancers,
using the upper confidence limit (IRR 1.54), 6.3
cases (0.4% of 1618 cases) would be attributable to
living near a NPP. Exposure to radioactivity set free
by the nuclear facilities is unlikely to explain an
excess in cancer risk in their vicinity. The NPPs are
responsible for <1/500 of the total radiation received
yearly by people living near NPPs; the main sources
are natural radiation and medical examinations.16
Other hypotheses that could explain a link between
leukaemia and NPPs include paternal exposure to ra-
diation before the child’s conception35 or an infectious
agent linked to population mixing near NPP sites.31
Conclusions
In summary, this nationwide cohort study, adjusting
for confounders and using exact distances from resi-
dence at birth and diagnosis to the nearest NPPs,
found little evidence for an association between the
risk of childhood cancer and living near NPPs.
Supplementary Data
Supplementary Data are available at IJE online.
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KEY MESSAGES
 This large-scale study examined the association between childhood cancer and residence near nuclear
power plants at birth and at diagnosis.
 The study found little evidence of an association, either for residence at birth or residence at diag-
nosis, but the number of exposed cases was small and confidence intervals wide.
 Results remained consistent after adjustment for potential confounders and in a number of sensitivity
analyses.
 A major strength of this study was the nationwide cohort approach, leaving little room for selection
bias.
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